Market Tracker

08/25 5:39am ET

Agenus Inc (NASDAQ:AGEN)

5.85
Delayed Data
As of Aug 24
 -0.20 / -3.31%
Today’s Change
2.61
Today|||52-Week Range
7.45
+28.85%
Year-to-Date
2 Cancer Therapy Stocks That Are Ridiculously Cheap Right Now
Aug 18 / MotleyFool.com - Paid Partner Content
Why Agenus (AGEN) Stock Might be a Great Pick
Aug 12 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close6.05
Today’s open6.08
Day’s range5.83 - 6.29
Volume1,404,823
Average volume (3 months)1,040,779
Market cap$526.3M
Dividend yield--
Data as of 08/24/2016

Growth & Valuation

Earnings growth (last year)-59.15%
Earnings growth (this year)-12.21%
Earnings growth (next 5 years)+1.00%
Revenue growth (last year)+255.67%
P/E ratioNM
Price/Sales14.31
Price/Book7.39

Competitors

 Today’s
change
Today’s
% change
ADAPAdaptimmune Therapeu...-0.23-3.19%
XBITXBiotech Inc-1.46-9.36%
BLCMBellicum Pharmaceuti...-1.42-7.63%
AERIAerie Pharmaceutical...-0.69-3.50%
Data as of 08/24/2016

Financials

Next reporting dateOctober 20, 2016
EPS forecast (this quarter)-$0.29
Annual revenue (last year)$24.8M
Annual profit (last year)-$87.9M
Net profit margin-354.12%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Garo H. Armen
Chief Financial &
Accounting Officer
Christine M. Klaskin
Corporate headquarters
Lexington, Massachusetts

Forecasts